Myriad Genetics, Inc. (MYGN)
7.215
-0.08
(-1.16%)
USD |
NASDAQ |
Dec 12, 16:00
7.215
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics EPS Diluted (Quarterly): -0.2943 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Neogen Corp. | 0.1672 |
| Phibro Animal Health Corp. | 0.649 |
| Celldex Therapeutics, Inc. | -1.009 |
| Atossa Therapeutics, Inc. | -0.0673 |
| Abeona Therapeutics, Inc. | -0.0952 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.40M |
| Revenue (Quarterly) | 205.70M |
| Total Expenses (Quarterly) | 233.10M |
| Enterprise Value | 747.36M |
| Gross Profit Margin (Quarterly) | 66.07% |
| Profit Margin (Quarterly) | -13.32% |
| Earnings Yield | -60.08% |
| Normalized Earnings Yield | -24.56 |